Phase 2 Lung Cancer Trial, Not Yet Recruiting NCT07076914 Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Condition: Lung Cancer
Back to Lung Cancer

Phase 2 Lung Cancer Trial, Not Yet Recruiting

NCT07076914
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 18 years of age or older
  • People who are willing to give their consent to participate in the trial
  • People whose general physical functioning falls within a certain range, meaning they are able to at least care for themselves even if unable to do all normal activities (confirm with trial site)
  • People who have a life expectancy of at least 3 months
  • People who have been diagnosed with a primary lung cancer of any stage, including non-small cell or small cell lung cancer — a confirmed tissue diagnosis is preferred but not always required
  • People who are scheduled to receive a radiation treatment course of at least 40 Gy in 15 treatment sessions, or an equivalent amount (confirm with trial site for specific schedules)
  • People whose radiation treatment plan shows that a sufficient portion of the esophagus (the swallowing tube) will receive a high level of radiation dose (confirm with trial site)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have serious other health conditions that would make radiation treatment unsafe
  • People who have used proton pump inhibitors (a type of medication commonly used for acid reflux or heartburn) in the 3 months before joining the trial
  • People who have a known allergy to proton pump inhibitor medications
  • People who already have painful swallowing before the trial begins
  • People who are pregnant or currently breastfeeding
  • Note: having had previous radiation treatment to the chest area does not automatically prevent someone from joining, provided the combined radiation doses meet standard safety limits as determined by the treating radiation oncologist (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026

Contact this trial

Phone: 519-685-8650

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
2 October 2025
Est. completion
2 January 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Worst patient-reported esophageal pain score during radiation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov